相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis
Siwen Gong et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2019)
Targeted inhibition of Axl receptor tyrosine kinase ameliorates anti-GBM-induced lupus-like nephritis
Yuxuan Zhen et al.
JOURNAL OF AUTOIMMUNITY (2018)
Mechanism of Mer receptor tyrosine kinase inhibition of glomerular endothelial cell inflammation
Yuxuan Zhen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Axl inhibitors as novel cancer therapeutic agents
Yingying Shen et al.
LIFE SCIENCES (2018)
Targeting Gas6/TAM in cancer cells and tumor microenvironment
Guiling Wu et al.
MOLECULAR CANCER (2018)
The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system
Farrah Blades et al.
GLIA (2018)
The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview
Martha Wium et al.
CELLS (2018)
Update on Lupus Nephritis
Salem Almaani et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
The TAM Receptor Tyro3 Regulates Myelination in the Central Nervous System
Rainer Akkermann et al.
GLIA (2017)
Phosphatidylserine Is the Signal for TAM Receptors and Their Ligands
Greg Lemke
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Increased Circulating and Urinary Levels of Soluble TAM Receptors in Diabetic Nephropathy
Peter Ochodnicky et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy
Wenni Li et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2017)
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The emerging role of coagulation proteases in kidney disease
Thati Madhusudhan et al.
NATURE REVIEWS NEPHROLOGY (2016)
Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE
Jacob J. Orme et al.
CLINICAL IMMUNOLOGY (2016)
Opposing Roles of Tyrosine Kinase Receptors Mer and Axl Determine Clinical Outcomes in Experimental Immune-Mediated Nephritis
Yuxuan Zhen et al.
JOURNAL OF IMMUNOLOGY (2016)
The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity
Pamela Y. Chan et al.
SCIENCE (2016)
The Receptor Tyrosine Kinase AXL in Cancer Progression
Erinn B. Rankin et al.
CANCERS (2016)
TAM Receptor Signaling in Immune Homeostasis
Carla V. Rothlin et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
MERTK as negative regulator of human T cell activation
Raquel Cabezon et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in Juvenile-onset Systemic Lupus Erythematosus
Lucy Ballantine et al.
PEDIATRIC RHEUMATOLOGY (2015)
Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy
Hege Lynum Pedersen et al.
SEMINARS IN NEPHROLOGY (2015)
Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells
Nitu Bansal et al.
ONCOTARGET (2015)
TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
Jonathan H. M. van der Meer et al.
BLOOD (2014)
Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
Wen-I Tsou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus
H. Zhu et al.
LUPUS (2014)
Diversification of TAM receptor tyrosine kinase function
Anna Zagorska et al.
NATURE IMMUNOLOGY (2014)
Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy
Brendan A. Hilliard et al.
ARTHRITIS RESEARCH & THERAPY (2014)
The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
Emmy D. G. Fleuren et al.
ONCOTARGET (2014)
Axl as a mediator of cellular growth and survival
Haley Axelrod et al.
ONCOTARGET (2014)
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities
Erin D. Lew et al.
ELIFE (2014)
The Expression and Clinical Significance of Different Forms of Mer Receptor Tyrosine Kinase in Systemic Lupus Erythematosus
Huaqun Zhu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Gas6 gains entry into the coagulation cascade
Jonathan H. Foley et al.
BLOOD (2013)
T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
Eugenio A. Carrera Silva et al.
IMMUNITY (2013)
Prolonged Apoptotic Cell Accumulation in Germinal Centers of Mer-Deficient Mice Causes Elevated B Cell and CD4+ Th Cell Responses Leading to Autoantibody Production
Tahsin N. Khan et al.
JOURNAL OF IMMUNOLOGY (2013)
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Keith M. Giles et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Dual Involvement of Growth Arrest-Specific Gene 6 in the Early Phase of Human IgA Nephropathy
Kojiro Nagai et al.
PLOS ONE (2013)
Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity
Pedro Recarte-Pelz et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Upregulation of Mer Receptor Tyrosine Kinase Signaling Attenuated Lipopolysaccharide-Induced Lung Inflammation
Ji-Yeon Choi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Galectin-3 is a new MerTK-specific eat-me signal
Nora B. Caberoy et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with Systemic lupus erythematosus and Behcets disease
Tamer A. Gheita et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Tubby regulates microglial phagocytosis through MerTK
Nora B. Caberoy et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure
Iris J. Lee et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis
Tal Burstyn-Cohen et al.
NEURON (2012)
Targeting Axl and Mer Kinases in Cancer
Anupam Verma et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
Carl Ekman et al.
RHEUMATOLOGY (2011)
Disturbances of apoptotic cell clearance in systemic lupus erythematosus
Wen-Hai Shao et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
Jun Wu et al.
ARTHRITIS RESEARCH & THERAPY (2011)
TAM receptors and the clearance of apoptotic cells
Greg Lemke et al.
CLEARANCE OF DYING CELLS IN HEALTHY AND DISEASED IMMUNE SYSTEMS (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis
Wen-Hai Shao et al.
CLINICAL IMMUNOLOGY (2010)
TAM receptor signaling and autoimmune disease
Carla V. Rothlin et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis
Nora B. Caberoy et al.
EMBO JOURNAL (2010)
Impaired Apoptotic Cell Clearance in the Germinal Center by Mer-Deficient Tingible Body Macrophages Leads to Enhanced Antibody-Forming Cell and Germinal Center Responses
Ziaur S. M. Rahman et al.
JOURNAL OF IMMUNOLOGY (2010)
Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood
C. Ekman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
The role of defective clearance of apoptotic cells in systemic autoimmunity
Luis E. Munoz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
Chang-Hee Suh et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Up-Regulation of Soluble Axl and Mer Receptor Tyrosine Kinases Negatively Correlates with Gas6 in Established Multiple Sclerosis Lesions
Jason G. Weinger et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Experimental anti-GBM nephritis as an analytical tool for studying spontaneous lupus nephritis
Yong Du et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
The mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus
Wen-Hai Shao et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
TAM receptors are pleiotropic inhibitors of the innate immune response
Carla V. Rothlin et al.
CELL (2007)
The tale of protein S and C4b-binding protein, a story of affection
Bjorn Dahlback
THROMBOSIS AND HAEMOSTASIS (2007)
The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis
Haikun Wang et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases
A Fiebeler et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiology
M Yanagita
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2004)
Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy
K Nagai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase
PL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis
M Yanagita et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
A Angelillo-Scherrer et al.
NATURE MEDICINE (2001)
分享论文
